Neurofibromin (Nf1) is required for skeletal muscle development
Open Access
- 9 April 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 20 (14), 2697-2709
- https://doi.org/10.1093/hmg/ddr149
Abstract
Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encoding a Ras-GAP protein, neurofibromin, which negatively regulates Ras signaling. Besides neuroectodermal malformations and tumors, the skeletal system is often affected (e.g. scoliosis and long bone dysplasia) demonstrating the importance of neurofibromin for development and maintenance of the musculoskeletal system. Here, we focus on the role of neurofibromin in skeletal muscle development. Nf1 gene inactivation in the early limb bud mesenchyme using Prx1-cre (Nf1Prx1) resulted in muscle dystrophy characterized by fibrosis, reduced number of muscle fibers and reduced muscle force. This was caused by an early defect in myogenesis affecting the terminal differentiation of myoblasts between E12.5 and E14.5. In parallel, the muscle connective tissue cells exhibited increased proliferation at E14.5 and an increase in the amount of connective tissue as early as E16.5. These changes were accompanied by excessive mitogen-activated protein kinase pathway activation. Satellite cells isolated from Nf1Prx1 mice showed normal self-renewal, but their differentiation was impaired as indicated by diminished myotube formation. Our results demonstrate a requirement of neurofibromin for muscle formation and maintenance. This previously unrecognized function of neurofibromin may contribute to the musculoskeletal problems in NF1 patients.Keywords
This publication has 43 references indexed in Scilit:
- Tbx4 and Tbx5 Acting in Connective Tissue Are Required for Limb Muscle and Tendon PatterningDevelopmental Cell, 2010
- KEGG for representation and analysis of molecular networks involving diseases and drugsNucleic Acids Research, 2009
- A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasiaHuman Molecular Genetics, 2009
- Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic optionsAmerican Journal of Medical Genetics Part A, 2009
- Cardiomyocyte-Specific Loss of Neurofibromin Promotes Cardiac Hypertrophy and DysfunctionCirculation Research, 2009
- Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatinBMC Medicine, 2008
- ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiaeCell Metabolism, 2006
- Double Inactivation of NF1 in Tibial PseudarthrosisAmerican Journal of Human Genetics, 2006
- Regulation of myogenic differentiation in the developing limb budJournal of Anatomy, 2003
- UCP2 muscle gene transfer modifies mitochondrial membrane potentialInternational Journal of Obesity, 2001